Literature DB >> 22045868

Natural killer cell-produced IFN-γ and TNF-α induce target cell cytolysis through up-regulation of ICAM-1.

Ruipeng Wang1, Jessica J Jaw, Nicole C Stutzman, Zhongcheng Zou, Peter D Sun.   

Abstract

NK cells control tumor and virus-infected cells through releasing cytotoxic granules and proinflammatory cytokines. IFN-γ and TNF-α secretions and cytotoxicity are regarded as two distinct functions of NK cells with little synergy in between as results of early association of the two functions with distinct subsets of NK populations and of the studies showing target cells developing NK resistance upon IFN-γ treatment. Here, we show that IFN-γ and TNF-α synergistically enhance NK cell cytotoxicity through NF-κB-dependent up-regulation of ICAM-1 expression in target cells, thereby promoting their conjugate formation with NK cells. Neutralizing IFN-γ and TNF-α during cytolysis significantly impaired NK cell lysis of the target cells. Further, tumor cells exhibiting IFN-γ-inducible lysis are generally less-sensitive NK target cells but express inducible levels of ICAM-1. In contrast, sensitive NK targets tend to express higher but less-inducible ICAM-1. Their preferential induction in the lysis of insensitive NK target cells suggests that IFN-γ and TNF-α are functionally linked to and should be regarded as an integral part of NK cytolytic function.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22045868      PMCID: PMC3290424          DOI: 10.1189/jlb.0611308

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  51 in total

1.  DNA-PKcs controls an endosomal signaling pathway for a proinflammatory response by natural killer cells.

Authors:  Sumati Rajagopalan; Mark W Moyle; Irma Joosten; Eric O Long
Journal:  Sci Signal       Date:  2010-02-23       Impact factor: 8.192

2.  IFN-dependent down-regulation of the NKG2D ligand H60 on tumors.

Authors:  Jack D Bui; Leonidas N Carayannopoulos; Lewis L Lanier; Wayne M Yokoyama; Robert D Schreiber
Journal:  J Immunol       Date:  2006-01-15       Impact factor: 5.422

3.  Regulation of human NK-cell cytokine and chemokine production by target cell recognition.

Authors:  Cyril Fauriat; Eric O Long; Hans-Gustaf Ljunggren; Yenan T Bryceson
Journal:  Blood       Date:  2009-12-01       Impact factor: 22.113

4.  Ligands for natural killer cell-activating receptors are expressed upon the maturation of normal myelomonocytic cells but at low levels in acute myeloid leukemias.

Authors:  Pegah Nowbakht; Mihai-Constantin S Ionescu; Andreas Rohner; Christian P Kalberer; Emmanuel Rossy; Lucia Mori; David Cosman; Gennaro De Libero; Aleksandra Wodnar-Filipowicz
Journal:  Blood       Date:  2005-01-18       Impact factor: 22.113

5.  HO-1 underlies resistance of AML cells to TNF-induced apoptosis.

Authors:  Stuart A Rushworth; David J MacEwan
Journal:  Blood       Date:  2008-01-17       Impact factor: 22.113

6.  Interferon-gamma down-regulates NKG2D ligand expression and impairs the NKG2D-mediated cytolysis of MHC class I-deficient melanoma by natural killer cells.

Authors:  Nicole Schwinn; Daria Vokhminova; Antje Sucker; Sonja Textor; Sandra Striegel; Iris Moll; Norman Nausch; Jochen Tuettenberg; Alexander Steinle; Adelheid Cerwenka; Dirk Schadendorf; Annette Paschen
Journal:  Int J Cancer       Date:  2009-04-01       Impact factor: 7.396

Review 7.  Tumour necrosis factor and cancer.

Authors:  Frances Balkwill
Journal:  Nat Rev Cancer       Date:  2009-04-03       Impact factor: 60.716

Review 8.  Human natural killer cells.

Authors:  Michael A Caligiuri
Journal:  Blood       Date:  2008-08-01       Impact factor: 22.113

Review 9.  Negative signaling by inhibitory receptors: the NK cell paradigm.

Authors:  Eric O Long
Journal:  Immunol Rev       Date:  2008-08       Impact factor: 12.988

10.  The B7 family member B7-H6 is a tumor cell ligand for the activating natural killer cell receptor NKp30 in humans.

Authors:  Cameron S Brandt; Myriam Baratin; Eugene C Yi; Jacob Kennedy; Zeren Gao; Brian Fox; Betty Haldeman; Craig D Ostrander; Tomonori Kaifu; Christian Chabannon; Alessandro Moretta; Robert West; Wenfeng Xu; Eric Vivier; Steven D Levin
Journal:  J Exp Med       Date:  2009-06-15       Impact factor: 14.307

View more
  82 in total

1.  Grainyhead-like-2 confers NK-sensitivity through interactions with epigenetic modifiers.

Authors:  Ian MacFawn; Hannah Wilson; Luke A Selth; Ian Leighton; Ilya Serebriiskii; R Christopher Bleackley; Osama Elzamzamy; Joshua Farris; Phillip M Pifer; Jennifer Richer; Steven M Frisch
Journal:  Mol Immunol       Date:  2018-11-30       Impact factor: 4.407

2.  Human and murine IL2 receptors differentially respond to the human-IL2 component of immunocytokines.

Authors:  Zulmarie Perez Horta; Swetha Saseedhar; Alexander L Rakhmilevich; Lakeesha Carmichael; Jacquelyn A Hank; Margaret Boyden; Stephen D Gillies; Paul M Sondel
Journal:  Oncoimmunology       Date:  2018-05-07       Impact factor: 8.110

3.  IL-15 regulates fibrosis and inflammation in a mouse model of chronic pancreatitis.

Authors:  Murli Manohar; Hemanth Kumar Kandikattu; Alok Kumar Verma; Anil Mishra
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2018-09-13       Impact factor: 4.052

4.  A Listeria-derived polypeptide promotes in vivo activation of NK cells for antitumor therapy.

Authors:  Amber L Ortiz; Laurel L Lenz
Journal:  Immunohorizons       Date:  2017-06-26

5.  Anti-BAFF-R antibody VAY-736 demonstrates promising preclinical activity in CLL and enhances effectiveness of ibrutinib.

Authors:  Emily M McWilliams; Christopher R Lucas; Timothy Chen; Bonnie K Harrington; Ronni Wasmuth; Amanda Campbell; Kerry A Rogers; Carolyn M Cheney; Xiaokui Mo; Leslie A Andritsos; Farrukh T Awan; Jennifer Woyach; William E Carson; Jonathan Butchar; Susheela Tridandapani; Erin Hertlein; Carlos E Castro; Natarajan Muthusamy; John C Byrd
Journal:  Blood Adv       Date:  2019-02-12

6.  NK cell-produced IFN-γ regulates cell growth and apoptosis of colorectal cancer by regulating IL-15.

Authors:  Feng Cui; Di Qu; Ruya Sun; Mingming Zhang; Kejun Nan
Journal:  Exp Ther Med       Date:  2019-12-18       Impact factor: 2.447

7.  Combination Cancer Therapy Using Chimeric Antigen Receptor-Engineered Natural Killer Cells as Drug Carriers.

Authors:  Elizabeth L Siegler; Yu Jeong Kim; Xianhui Chen; Natnaree Siriwon; John Mac; Jennifer A Rohrs; Paul D Bryson; Pin Wang
Journal:  Mol Ther       Date:  2017-08-19       Impact factor: 11.454

8.  Combined IL-15 and IL-12 drives the generation of CD34+-derived natural killer cells with superior maturation and alloreactivity potential following adoptive transfer.

Authors:  Jeannette Cany; Anniek B van der Waart; Jan Spanholtz; Marleen Tordoir; Joop H Jansen; Robbert van der Voort; Nicolaas M Schaap; Harry Dolstra
Journal:  Oncoimmunology       Date:  2015-04-01       Impact factor: 8.110

9.  In vivo Anti-Cancer Effects of Resveratrol Mediated by NK Cell Activation.

Authors:  Yoojin Lee; Heewook Shin; Jongsun Kim
Journal:  J Innate Immun       Date:  2020-09-16       Impact factor: 7.349

10.  Tumoral NKG2D alters cell cycle of acute myeloid leukemic cells and reduces NK cell-mediated immune surveillance.

Authors:  Mingying Tang; Desmond Omane Acheampong; Youfu Wang; Wei Xie; Min Wang; Juan Zhang
Journal:  Immunol Res       Date:  2016-06       Impact factor: 2.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.